AnalystBook Research · Company Intelligence

CoinShares Bitcoin ETF

BRRRNasdaq

Built from CoinShares Bitcoin ETF's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

CoinShares Bitcoin ETF's FY2025 net result swung to a $49.7M loss as trust equity fell 38.8%, reflecting Bitcoin-exposure volatility rather than a normal operating business.

The read at a glance✓ Audited against SEC data
  • Business mixSpot Bitcoin ETF trustNote
  • RevenueNot a standard revenue issuerNote
  • Net income-$49.7MWatch
  • Equity$505.4M, -38.8%Watch
  • Cash flowStandard rows unavailableNote
  • Insiders0 purchases / 0 salesNote
  • AccountingForensic screens unavailableNote

Business

CoinShares Bitcoin ETF is a Delaware statutory trust whose shares represent fractional beneficial interests in the trust's Bitcoin exposure.

Leadership changes

From CoinShares Bitcoin ETF's own filings, the day they're filed.

  • Jared Demark · chief executive officer · departureeff. 2024-09-30
  • Leah Wald · chief executive officer · departureeff. 2024-06-14
  • Steven McClurg In · chief executive officer · departureeff. 2024-06-14

Latest filings

  • 10-Q · Quarterly report2026-08-12
  • 10-Q · Quarterly report2026-05-12
  • 10-K · Annual report2026-03-10
  • 10-Q · Quarterly report2025-11-13
  • 10-Q · Quarterly report2025-08-13
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about CoinShares Bitcoin ETF, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.